Andrew Andrew VanDemark

Dr. Andrew Andrew VanDemark

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Cell
Verified
Journal Article
Closed access
SWSally E. Wenzel
Sally E. Wenzel
YTYulia Y. Tyurina
Yulia Y. Tyurina
JZJinming Zhao
Jinming Zhao
CCClaudette M. St. Croix
Claudette M. St. Croix
HDHaider H. Dar
Haider H. Dar
VKValerian E. Kagan
Valerian E. Kagan

1 June 2001 in Cell
Verified
Journal Article
Closed access
AVAndrew Andrew VanDemark
Andrew Andrew VanDemark
RHRoseanne M. Hofmann
Roseanne M. Hofmann
CTColleen Tsui
Colleen Tsui
CPCecile M. Pickart
Cecile M. Pickart
CWCynthia Wolberger
Cynthia Wolberger

23 October 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
BWBrett D. Welch
Brett D. Welch
AVAndrew Andrew VanDemark
Andrew Andrew VanDemark
AHAnnie Heroux
Annie Heroux
CHChristopher P. Hill
Christopher P. Hill
MKMichael S. Kay
Michael S. Kay
During HIV-1 entry, the highly conserved gp41 N-trimer pocket region becomes transiently exposed and vulnerable to inhibition. Using mirror-image phage display and structure-assisted design, we have discovered protease-resistant D-amino acid peptides (D-peptides) that bind the N-trimer pocket with high affinity and potently inhibit viral entry. We also report high-resolution crystal structures of two of these D-peptides in complex with a pocket mimic that suggest sources of their high potency. A trimeric version of one of these peptides is the most potent pocket-specific entry inhibitor yet reported by three orders of magnitude (IC50= 250 pM). These results are the first demonstration that D-peptides can form specific and high-affinity interactions with natural protein targets and strengthen their promise as therapeutic agents. The D-peptides described here address limitations associated with current L-peptide entry inhibitors and are promising leads for the prevention and treatment of HIV/AIDS.

10 March 2023 in Science
Verified
Journal Article
Closed access
KHKevin G. Hicks
Kevin G. Hicks
ACAhmad A. Cluntun
Ahmad A. Cluntun
HSHeidi L. Schubert
Heidi L. Schubert
SHSean R. Hackett
Sean R. Hackett
JBJordan A. Berg
Jordan A. Berg
JRJared Rutter
Jared Rutter
Metabolic networks are interconnected and influence diverse cellular processes. The protein-metabolite interactions that mediate these networks are frequently low affinity and challenging to systematically discover. We developed mass spectrometry integrated with equilibrium dialysis for the discovery of allostery systematically (MIDAS) to identify such interactions. Analysis of 33 enzymes from human carbohydrate metabolism identified 830 protein-metabolite interactions, including known regulators, substrates, and products as well as previously unreported interactions. We functionally validated a subset of interactions, including the isoform-specific inhibition of lactate dehydrogenase by long-chain acyl–coenzyme A. Cell treatment with fatty acids caused a loss of pyruvate-lactate interconversion dependent on lactate dehydrogenase isoform expression. These protein-metabolite interactions may contribute to the dynamic, tissue-specific metabolic flexibility that enables growth and survival in an ever-changing nutrient environment.

1 September 2007 in Molecular Cell
Verified
Journal Article
Closed access
AVAndrew Andrew VanDemark
Andrew Andrew VanDemark
MKMargaret M. Kasten
Margaret M. Kasten
EFElliott Ferris
Elliott Ferris
AHAnnie Heroux
Annie Heroux
CHChristopher P. Hill
Christopher P. Hill
BCBradley R. Cairns
Bradley R. Cairns

1 May 2006 in Molecular Cell
Verified
Journal Article
Closed access
AVAndrew Andrew VanDemark
Andrew Andrew VanDemark
MBMary Blanksma
Mary Blanksma
EFElliott Ferris
Elliott Ferris
AHAnnie Heroux
Annie Heroux
CHChristopher P. Hill
Christopher P. Hill
TFTim Formosa
Tim Formosa